Skip Navigation LinksHome > Membership > Governance and Policies > Committees & Sections > Cellular Therapies Section Subsections

Skip Navigation LinksHome > Membership > Governance and Policies > Committees & Sections > Cellular Therapies Section Subsections

Cellular Therapies Section Subsections

Groups called subsections allow members of the CT Section to focus on specific topic areas. Subsections work to identify challenges and develop materials to meet the needs of the field. Section participation is open to all AABB individual members who may enroll in any subsection(s) they choose.

CT Spanish Language
Cord Blood
CT Asia Pacific Group
CT Management
CT Product Collection and Clinical Practices
CT Product Manufacturing and Testing
CT Quality Operations
CT Regulatory Affairs
Novel Therapies and CT Product Development

CT Spanish Language

This group is for Spanish-speaking members or those members located in Spanish-speaking regions. Members will be able to join live discussions and participate with fellow SLS members in regular subsection meetings held at 'convenient' times for the zones encompassed in the Latin America region. The SLS will address CT issues related to cord blood; donor qualification; manufacturing; storage and transport challenges; quality operations; regulatory issues; and development. The group will also address specific regional issues for developing programs. All interested individual AABB members who speak Spanish and would like to share their CT interests, insights and expertise in may join. (Meets 3rd Wednesdays at 10:00am ET monthly. Leader: Celina Montemayor/Associate Leader: Angel Guerra)

Cord Blood

This group works on topics such as donor issues for public banking (recruitment, consent, screening/testing), manufacturing, storage and transport challenges, licensure, international issues, and private and family banking issues. (Meets 1st Thursdays at 1:00pm ET monthly, Leader: Salem Akel/Associate Leader: Gwen Epstein)

CT Asia Pacific Group

For members located in the Asia-Pacific region, a designated group called the Asia Pacific Group or APG is available. Members will be able to join live discussions and directly participate with fellow APG members in regular subsection meetings held at 'convenient' times for the zones encompassed in this region. Countries in the region include Australia, China, Guam, Hong Kong, India, Indonesia, Japan, Malaysia, New Zealand, Philippines, Qatar, Singapore, South Korea, Sri Lanka, Taiwan, Thailand and Vietnam.

CT issues related to cord blood, donor qualification, manufacturing, storage and transport challenges, as well as quality operations, regulatory, development and specific regional issues will be addressed. The APG meeting time is tailored to those in the Asia-Pacific; however, all interested individual AABB members who would like to share their CT interests, insights and expertise may join. (Meets 2nd Wednesdays, monthly at 0400 UTC coordinated universal time, Leader: David Stroncek/Associate Leaders: Arun Prasath)

CT Management

This group works on topics such as reimbursement issues (Centers for Medicare/Medicaid (CMS), Food and Drug Administration (FDA)), funding sources for cell therapy development and clinical trials - federal and other public sources, venture capital, charitable donations (disease advocacy groups), as well as the administrative business (e.g. budgets, human resources , workload recording, cost accounting, job descriptions, staffing models, personnel management/project management, strategic planning, Lean/process engineering tools, expense reduction initiatives and cost containment) of cell therapy production. (Meets 2nd Tuesdays at 12:00pm ET bimonthly, Leader: Suzanne W. Dworsky/Associate Leader: Brian Jones)

CT Product Collection and Clinical Practices

This group focuses primarily on clinical topics associated with the collection, transport, utilization and outcomes of cellular therapy products obtained from peripheral blood by apheresis, bone marrow, cord blood and other sources by the use of new technologies. Clinical topics include donor and recipient screening, eligibility, mobilization and collection, informed consent, product administration and infusion-related adverse events. (Meets 2nd Mondays at 1:00pm ET monthly, Leader: Thomas Spitzer/Associate Leaders: Jay Raval and Joseph ‘Yossi’ Schwartz)

CT Product Manufacturing and Testing

This group works on technical topics and operational aspects related to the manufacturing and testing of CT products such as cryopreservation, cell separation and selection, automation, product characterization, assay development, validation and implementation. (Meets 3rd Thursdays at 11:00am ET monthly,  Leader: Leader: Ronit Slotky/Associate Leader: Yen-Michael S. Hsu)

CT Quality Operations

This group works on topics such as Quality Program design, risk assessment and risk management, vendor and supply qualification, facility, environmental and operational controls. (Meets 3rd Thursdays at 2:00pm ET monthly, Leader: Ed Brindle/Associate Leader: Deb Sesok-Pizzini)

CT Regulatory Affairs

This group works on US and international topics involving regulations, guidance and policies from a variety of sources. Examples include FDA, Health Canada, European Medicine Evaluation Agency (EMEA), Office for Human Research Protections (OHRP)), NIH, Regulatory Affairs Certification (RAC), and Health Resources and Services Agency (HRSA). (Meets 3rd Tuesdays at 11:00am ET monthly, Leader: Ljiljana Vasovic/Associate Leader: Olive Sturtevant)

Novel Therapies and CT Product Development

This group works on topics such as 'new' research and preclinical studies, new devices for manipulating cells as well as later-stage cellular product development, validation, and technology transfer for clinical production. Examples include developments in the areas of induced pluripotent cells (iPS cells), tissue-derived cells, genetic engineering, structural materials, and biomaterials to name a few. (Meets 2nd Thursdays at 12:00pm ET monthly, Leader: Magali Fontaine/Associate Leader: Richard Schaefer)